Viewing Study NCT00891293


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-05-17 @ 3:15 PM
Study NCT ID: NCT00891293
Status: COMPLETED
Last Update Posted: 2011-01-25
First Post: 2009-04-30
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertriglyceridemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None omega-3-acid ethyl esters View
None Very high triglycerides View
None Lovaza View
None fenofibrate View